Reference pricing for pharmaceuticals: is the Australia-United States Free Trade Agreement affecting Australia's Pharmaceutical Benefits Scheme?

被引：15
作者：
Faunce, Thomas A.
机构：
[1] Australian Natl Univ, Sch Med, Canberra, ACT, Australia
[2] Australian Natl Univ, Coll Law, Canberra, ACT, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2007年 / 187卷 / 04期
关键词：
D O I：
10.5694/j.1326-5377.2007.tb01209.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Unless the federal government changes the course of our medicines policy with intention, Australia's pricing of patented pharmaceuticals is likely to follow inequitable US trends.
引用
收藏
页码：240 / 242
页数：3
相关论文
共 12 条
  • [1] *AUSTR GOV DEP HLT, PBS LAT NEWS
  • [2] *AUSTR GOV DEP HLT, PBAC OUTC PUBL SUMM
  • [3] Australian Government. Department of Health, NAT MED POL
  • [4] DEADY S, 2004, SENATE SELECT COMMIT
  • [5] Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy
    Faunce, Thomas
    Doran, Evan
    Henry, David
    Drahos, Peter
    Searles, Andrew
    Pekarsky, Brita
    Neville, Warwick
    [J]. GLOBALIZATION AND HEALTH, 2005, 1 (1)
  • [6] Faunce Thomas A, 2007, Aust New Zealand Health Policy, V4, P8, DOI 10.1186/1743-8462-4-8
  • [7] Will the Australia-United States free trade agreement undermine the pharmaceutical benefits scheme?
    Harvey, KJ
    Faunce, TA
    Lokuge, B
    Drahos, P
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (05) : 256 - 259
  • [8] LAMING A, 2006, LETS OVERHAUL PHARM, P10
  • [9] LOPERT R, 2004, SENATE SELECT COMMIT
  • [10] Reform of drug regulation - Beyond an independent drug-safety board
    Ray, WA
    Stein, CM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (02) : 194 - 201
12